Marta Ruiz-Santaquiteria
Overview
    Explore the profile of Marta Ruiz-Santaquiteria including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              6
            
            
              Citations
              53
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Ruiz-Santaquiteria M, Illescas B, Abdelnabi R, Boonen A, Mills A, Marti-Mari O, et al.
  
  
    Chemistry
    . 2021 Apr;
          27(41):10700-10710.
    
    PMID: 33851758
  
  
          Unprecedented 3D hexa-adducts of [60]fullerene peripherally decorated with twelve tryptophan (Trp) or tyrosine (Tyr) residues have been synthesized. Studies on the antiviral activity of these novel compounds against HIV and...
      
2.
        
    
    Revuelto A, Ruiz-Santaquiteria M, de Lucio H, Gamo A, Carriles A, Gutierrez K, et al.
  
  
    ACS Infect Dis
    . 2019 Apr;
          5(6):873-891.
    
    PMID: 30983322
  
  
          Disruption of protein-protein interactions of essential oligomeric enzymes by small molecules represents a significant challenge. We recently reported some linear and cyclic peptides derived from an α-helical region present in...
      
3.
        
    
    Ruiz-Santaquiteria M, de Castro S, Toro M, de Lucio H, Gutierrez K, Sanchez-Murcia P, et al.
  
  
    Eur J Med Chem
    . 2018 Mar;
          149:238-247.
    
    PMID: 29501944
  
  
          Trypanothione reductase (TryR) is a well-established target in the search for novel antitrypanosomal and antileishmanial agents. We have previously identified linear and lactam-bridged 13-residue peptides derived from an α-helical region...
      
4.
        
    
    de Lucio H, Gamo A, Ruiz-Santaquiteria M, de Castro S, Sanchez-Murcia P, Toro M, et al.
  
  
    Eur J Med Chem
    . 2017 Oct;
          140:615-623.
    
    PMID: 29017116
  
  
          The objective of the current study was to enhance the proteolytic stability of peptide-based inhibitors that target critical protein-protein interactions at the dimerization interface of Leishmania infantum trypanothione reductase (Li-TryR)...
      
5.
        
    
    Ruiz-Santaquiteria M, Sanchez-Murcia P, Toro M, de Lucio H, Gutierrez K, de Castro S, et al.
  
  
    Eur J Med Chem
    . 2017 Apr;
          135:49-59.
    
    PMID: 28431354
  
  
          A series of 9-mer and 13-mer amide-bridged cyclic peptides derived from the linear prototype Ac-PKIIQSVGIS-Nle-K-Nle-NH (Toro et al. ChemBioChem2013) has been designed and synthesized by introduction of the lactam between...
      
6.
        
    
    Toro M, Sanchez-Murcia P, Moreno D, Ruiz-Santaquiteria M, Alzate J, Negri A, et al.
  
  
    Chembiochem
    . 2013 Jun;
          14(10):1212-7.
    
    PMID: 23744811
  
  
          Binding at the interface: We tested the inhibitory activity of a set of peptide sequences derived from an α-helix of the dimeric trypanothione reductase from Leishmania infantum. Replacement of a...